Search | VHL Regional Portal

[Invasive mucormycosis in patients with hemoblastosis in St.-Petersburg].

Khostelidi, S N; Volkova, A G; Popova, M O; Bogomolova, T S; Kolbin, A S; Boichenko, É G; Podol'tseva, É I; Klimovich, A V; Belogurova, M B; Medvedeva, N V; Ziuzgin, I S; Zubarovskaia, L S; Vasil'eva, N V; Klimko, N N.

Antibiot Khimioter ; 58(7-8): 23-9, 2013.

Article in Russian | MEDLINE | ID: mdl-24757830

ABSTRACT

Thirty four patients with mucormycosis in 10 hospitals of St. Petersburg were observed in 2004-2013. The most frequent underlying diseases of mucormycosis were acute leukoses (64%). In 100% of the patients mucormycosis developed as a nosocomial infection. The risk factors, etiology, basic clinical signs and strategy in the treatment of mucormycosis were analyzed.

Subject(s)

Antifungal Agents/therapeutic use , Cross Infection/microbiology , Leukemia, Lymphocytic, Chronic, B-Cell/microbiology , Leukemia, Myeloid, Acute/microbiology , Mucormycosis/microbiology , Adolescent , Adult , Aged , Child , Child, Preschool , Cross Infection/complications , Cross Infection/drug therapy , Cross Infection/mortality , Female , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/complications , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/mortality , Leukemia, Myeloid, Acute/complications , Leukemia, Myeloid, Acute/drug therapy , Leukemia, Myeloid, Acute/mortality , Male , Middle Aged , Mucormycosis/complications , Mucormycosis/drug therapy , Mucormycosis/mortality , Prospective Studies , Rhizopus/drug effects , Rhizopus/growth & development , Rhizopus/isolation & purification , Risk Factors , Russia , Survival Analysis

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL